Brief: Aclaris Therapeutics Q4 Revenue USD 9.211 Million Vs. IBES Estimate USD 2.11 Million
27/02/2025 12:00
Feb 27 (Reuters) - Aclaris Therapeutics Q4 net income USD -96.552 million vs. IBES estimate USD -22.4 million.
Recent news on Aclaris Therapeutics
See all newsAclaris Therapeutics Q1 net loss widens on higher R&D spending
Brief: Aclaris Therapeutics Q1 EPS USD -0.15 Vs. IBES Estimate USD -0.16
Brief: Aclaris Therapeutics Says Positive Full Top Line Results From Phase 1A Clinical Trial Of ATI-055
Brief: Aclaris Therapeutics Completes Enrollment In Phase 2 Trial Of Bosakitug (Ati-045) In Atopic Dermatitis
Aclaris Q4 loss narrows, but misses analysts' expectations